Patents Assigned to CUORIPS INC.
  • Publication number: 20240197753
    Abstract: An object is to provide a pharmaceutical composition that improves cardiac function when administered during coronary artery bypass surgery for ischemic cardiomyopathy. A pharmaceutical composition for improving cardiac function comprising: (A) a release formulation comprising at least poly(lactic-co-glycolic acid) (PLGA) and a prostaglandin 12 receptor agonist, the PLGA having an average molecular weight of 10000 to 30000; and (B) a release formulation comprising at least poly(lactic-co-glycolic acid) (PLGA) and a prostaglandin 12 receptor agonist, the PLGA having an average molecular weight of 40000 to 60000.
    Type: Application
    Filed: March 25, 2022
    Publication date: June 20, 2024
    Applicants: OSAKA UNIVERSITY, CUORIPS INC.
    Inventors: Yoshiki SAWA, Shigeru MIYAGAWA, Yoshiki SAKAI, Yasuhiro YANAGI